BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma

Background. Stimulated thyroglobulin levels measured at the time of remnant ablation (A-hTg) and BRAFV600E mutation had shown prognostic value in predicting persistent disease in differentiated thyroid cancer (DTC). The aim of this study was to evaluate the prognostic role of A-hTg combined with the...

Full description

Bibliographic Details
Main Authors: Andrea Repaci, Valentina Vicennati, Alexandro Paccapelo, Ottavio Cavicchi, Nicola Salituro, Fabio Monari, Dario de Biase, Giovanni Tallini, Annalisa Altimari, Elisa Gruppioni, Michelangelo Fiorentino, Uberto Pagotto
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2019/3081497